Therapeutics is pleased to showcase its survival and clinical benefit data in MBC patients, including those with CNS ...

Scientists have uncovered a potential link between 2 specific bacteria strains and a certain cancer, implying a potential ...

By comparing cancer incidence rates with genomic surveillance data, researchers suggest that higher rates of certain cancers in the UK and other countries may be linked to two bacterial strains. These ...

cancer vaccine that targets KRAS-mutant tumors, at the ESMO Immuno-Oncology Congress 2024 in Geneva, Switzerland. ELI-002 was evaluated in individuals with mutant KRAS-driven colorectal or pancreatic ...

Innovative Immunotherapy Shows Promise in Early Clinical Trial for Breast Cancer Dec ... why the flu vaccine can perform poorly. They found that a specific type of immune cell, called T follicular ...

Updated Phase 1 data include a 16.3-month median recurrence-free survival ("mRFS") and 28.9-month median overall survival ("mOS") from full study population Strong correlation observed between mRFS an ...

For Americans, here’s what medical history and new research say about the bonuses of vaccines beyond preventing the diseases ...

More than 80% of patients with lung cancer receive care in their communities, but this can leave them vulnerable to gaps in care quality and delivery. Amivantamab's role in non–small cell lung ...

Cancer researchers at Fox Chase Cancer Center in Philadelphia see promise in personalized medicine to help crack the code on ...

Allogeneic whole-tumor-cell vaccines are derived from various tumor cell lines and are easier to prepare. Whole tumor cells are rendered replication-defective by radiation, frequently combined ...

Imagine a world in which a vaccine is a cream you rub onto your skin instead of a needle a health care worker pushes into one ...